MN HF544

Defines "clinician-administered drugs" as outpatient prescription drugs (excluding vaccines) that cannot be self-administered and are typically given by authorized health care providers in clinical settings like physician offices or hospital infusion centers.

Prohibits pharmacy benefit managers and health carriers from requiring clinician-administered drugs or their administration to be covered as pharmacy benefits.

Requires that enrollees be permitted to obtain clinician-administered drugs from any authorized health care provider or pharmacy of their choice without financial incentives or interference favoring specific providers or pharmacies.

Mandates that cost-sharing, coverage limitations, and reimbursement rates for clinician-administered drugs be identical regardless of whether they are obtained from an affiliated pharmacy, a plan-selected pharmacy, or an authorized health care provider.

Prohibits specialty pharmacies from dispensing clinician-administered medications directly to patients for transport to providers and allows but does not require home infusion pharmacy services or external infusion sites.

Effective January 1, 2024.